Monday, 12 April 2021

Healthcare solutions provider 'emids' acquires Quovantis Technologies

08 April 2021 | News

The deal signals the next chapter in the company’s focus on driving digital customer experience

image credit- Quovantis Technologies

image credit- Quovantis Technologies

emids, a leader in digital engineering and transformation solutions to the healthcare and life sciences industry, has announced the acquisition of New Delhi-based Quovantis Technologies, a user experience design and software development company that enables health technology and product companies to deliver compelling digital experiences for web, mobile and wearables. The terms of the deal were not disclosed.

Bengaluru-based emids, which has built its reputation as one of healthcare's most trusted partners for health information technology (HIT) engineering and development, is going strategically upstream with this latest deal on the heels of its acquisition earlier this year of design-led engineering firm Macadamian.

The combined expertise puts emids in a unique position, offering its clients industry-leading data science, engineering and business strategy acumen plus the ability to take an innovative idea from concept to MVP to full-scale enterprise solution and with speed to market.

Kumar Kolin, emids Chief Technology Officer, said “The addition of Quovantis now gives us permission to say, let us sit down with you to think about the problem you're trying to solve for, let's help you build, test and iterate that solution, and let's see it all the way through with you and help figure out how to scale it for the enterprise. This puts emids on the map as a top-tier product development partner, capable of the design, build and large-scale commercialization of novel digital ideas and technologies.”

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account






Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls